台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣東洋藥品工業股份有限公司 台北市南港區園區街3之1號3樓 (11821341) - doxorubicin hydrochloride(liposome) - 注射劑 - doxorubicin hydrochloride(liposome) (1003000615) (potency)mg - doxorubicin - 用於治療cd4數量低下(<200 cd4 lymphocytes/mm3）和黏膜、皮膚或內臟有病變的aids related kaposi's sarcoma的病人。用於治療曾接受第一線含鉑類藥物(platinum-based)化學治療而失敗者或再復發之進行性或轉移性卵巢癌病人。可用於單一治療有心臟疾病風險考量之轉移性乳癌患者。可與bortezomib併用治療於曾接受過至少一種治療方式且已經接受或不適宜接受骨髓移植的進展性多發性骨髓瘤病人。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438) - zidovudine - 膠囊劑 - zidovudine (0818000600) mg - zidovudine - 與其他抗反轉錄病毒併用治療後天性免疫缺乏症候群（ＡＩＤＳ）或與其有關之症狀（ＡＲＣ，ＡＩＤＳ　ＲＥＬＡＴＥＤ　ＣＯＭＰＬＥＸ），受到人類免疫缺乏病毒（ＨＩＶ）感染沒有症狀或只有初期輕度症狀而ＣＤ４Ｔ淋巴球數目小於５００／ｍｍ３病人的治療

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

濟生醫藥生技股份有限公司 新竹縣湖口鄉勝利村實踐路3號 (47154259) - l-isoleucine;;l-leucine;;lysine l- hcl h2o;;l-methionine;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-valine;;arginine l- hcl monohydrate;;histidine l- hcl monohydrate;;glycine (eq to aminoacetic acid)(eq to glycocoll) - 注射劑 - arginine l- hcl monohydrate (4020100372) gm; histidine l- hcl monohydrate (4020100922) gm; l-isoleucine (4020101002) gm; l-leucine (4020101202) gm; lysine l- hcl h2o (4020101362) gm; l-methionine (4020101502) gm; l-phenylalanine (4020101702) gm; l-threonine (4020102002) gm; l-tryptophan (4020102102) gm; l-valine (4020102302) gm; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) gm - amino acids and derivatives - 胃腸疾患而致蛋白質之消化吸收受障礙時之非經口之營養補給用、需要蛋白質時之補給

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

美商惠氏藥廠（亞洲）股份有限公司台灣分公司 台北市信義區松仁路100號42、43樓 (23984410) - temsirolimus - 注射劑 - temsirolimus (9250001400) mg - temsirolimus - 治療晚期腎細胞癌；患者需具有下列六個風險因子中至少三個以上因子：(1)距離初次診斷出腎細胞癌之時間未達一年、(2)karnofsky performance scale (kps)介於60至70之間、(3)血色素低於正常值、(4)矯正後血鈣值超過10mg/dl、(5)乳酸脫氫酶(lactate dehydrogenase)超過1.5倍正常值上限、(6)超過一個以上的器官有轉移病灶。用於曾經接受兩種化療處方治療失敗的成人被套細胞淋巴瘤

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣諾華股份有限公司 台北市中山區民生東路三段2號8樓 (01516589) - ruxolitinib phosphate - 錠劑 - 主成分 () ; ruxolitinib phosphate (1013004210) (eq. ruxolitinib freebase 5mg)mg - ruxolitinib - 1. 適用於治療中度風險或高風險之骨髓纖維化，包括原發性骨髓纖維化、真性紅血球增多症後骨髓纖維化、或血小板增多症後骨髓纖維化。2. 適用於接受hydroxyurea治療後有抗藥性或無耐受性的真性紅血球增多症。3. 移植物抗宿主疾病 (gvhd)：適用於治療12 歲以上之青少年及成人，且先前曾接受皮質類固醇(corticosteroids)或其它全身性治療後反應不佳的急或慢性移植物抗宿主疾病(acute or chronic graft-versus-host disease, gvhd)病人。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - l-isoleucine;;l-leucine;;lysine l- (hcl);;l-methionine;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-valine;;l-arginine;;l-histidine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-alanine;;l-proline;;l-aspartic acid;;asparagine l- monohydrate (eq to asparagine h2o l- );;acetylcysteine;;l-cysteine;;glutamic acid l-;;l-ornithine hcl;;l-serine;;tyrosine l-(n-acetyl);;l-tyrosine;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;potassium acetate;;magnesium acetate tetrahydrate;;sodium phosphate monobasic (eq to monosodium phosphate)(eq to sodium dihydrogen phosphate);;malic acid l-;;sodium hydroxide;;edetate disodium dihydrate (eq to disodium edetate dihydrate) - 注射劑 - potassium acetate (4008000100) 2.45gm; sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) 3.95gm; magnesium acetate tetrahydrate (4012001450) 0.56gm; l-alanine (4020100202) 13.70gm; l-arginine (4020100302) 9.20gm; l-aspartic acid (4020100402) 1.30gm; asparagine l- monohydrate (eq to asparagine h2o l- ) (4020100472) (3.72g) 3.27gm; l-cysteine (4020100502) 0.50gm; glutamic acid l- (4020100702) 4.60gm; l-histidine (4020100902) 5.20gm; l-isoleucine (4020101002) 5.10gm; l-leucine (4020101202) 8.90gm; l-methionine (4020101502) 3.80gm; l-ornithine hcl (4020101612) (3.20g) 2.5gm; l-phenylalanine (4020101702) 5.10gm; l-proline (4020101802) 8.90gm; l-serine (4020101902) 2.40gm; l-threonine (4020102002) 4.10gm; l-tryptophan (4020102102) 1.80gm; l-tyrosine (4020102202) 0.30gm; l-valine (4020102302) 4.80gm; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 7.90gm; lysine l- (hcl) (4020191312) (7.00g) 5.6gm; tyrosine l-(n-acetyl) (4020192212) (1.23g) 1.00gm; acetylcysteine (4800000100) 0.68gm; sodium phosphate monobasic (eq to monosodium phosphate)(eq to sodium dihydrogen phosphate) (5612002610) 1.40gm; edetate disodium dihydrate (eq to disodium edetate dihydrate) (6400000315) 0.050gm; malic acid l- (9600017802) 1.01gm; sodium hydroxide (9600028200) 0.20gm - amino acids - 不能攝取適當食物之患者之補助治療劑、蛋白質之消化吸收機能或合成利用障礙、嚴重創傷火傷骨折時蛋白質之補給、蛋白質攝取減少之營養失調症

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣費森尤斯卡比股份有限公司 台北市大安區仁愛路三段30號5樓32號5樓 (12980985) - l-isoleucine;;l-leucine;;l-lysine acetate;;l-methionine;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-valine;;l-arginine;;l-histidine;;l-alanine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-proline;;l-serine;;l-tyrosine;;taurine (eq to 2-aminoethane sulfonic acid) - 注射劑 - l-alanine (4020100202) mg; l-arginine (4020100302) mg; l-histidine (4020100902) mg; l-isoleucine (4020101002) mg; l-leucine (4020101202) mg; l-lysine acetate (4020101322) mg; l-methionine (4020101502) mg; l-phenylalanine (4020101702) mg; l-proline (4020101802) mg; l-serine (4020101902) mg; l-threonine (4020102002) mg; l-tryptophan (4020102102) mg; l-tyrosine (4020102202) mg; l-valine (4020102302) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; taurine (eq to 2-aminoethane sulfonic acid) (9200000900) mg - amino acids - 腸外營養補充劑。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

南光化學製藥股份有限公司 台南市新化區全興里中山路１００１號 (69275313) - l-isoleucine;;l-leucine;;lysine l- (acetate);;l-methionine;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-valine;;l-histidine;;l-cysteine hcl monohydrate - 注射劑 - l-cysteine hcl monohydrate (4020100552) 0.2mg; l-histidine (4020100902) 2.5mg; l-isoleucine (4020101002) 5.6mg; l-leucine (4020101202) 8.8mg; l-methionine (4020101502) 8.8mg; l-phenylalanine (4020101702) 8.8mg; l-threonine (4020102002) 4mg; l-tryptophan (4020102102) 2mg; l-valine (4020102302) 6.4mg; lysine l- (acetate) (4020191322) (9.03mg) 6.4mg - amino acids - 急慢性腎不全時氨基酸之補給。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

南光化學製藥股份有限公司 台南市新化區全興里中山路１００１號 (69275313) - isoleucine;;leucine;;lysine (acetate);;methionine;;phenylalanine;;threonine;;tryptophan;;valine;;alanine;;arginine;;histidine;;proline;;serine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;cysteine hcl monohydrate - 注射劑 - alanine (4020100200) mg; arginine (4020100300) mg; cysteine hcl monohydrate (4020100550) (0.29mg)mg; histidine (4020100900) mg; isoleucine (4020101000) mg; leucine (4020101200) mg; methionine (4020101500) mg; phenylalanine (4020101700) mg; proline (4020101800) mg; serine (4020101900) mg; threonine (4020102000) mg; tryptophan (4020102100) mg; valine (4020102300) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; lysine (acetate) (4020191320) (8.60mg)mg - amino acids - 治療肝硬化或急、慢性肝炎病人因該病所引發之肝昏迷，供給患有肝病病人所需之靜脈注射。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

傑特貝林有限公司 臺北市信義區基隆路1段333號16樓(1612室) (43836487) - immunoglobulin human - 注射液劑 - immunoglobulin human (8004000603) human plasma protein with at least 98% iggmg - immunoglobulins, normal human, for intravascular adm. - 作為替代療法：1.原發性免疫不全症(primary immunodeficiency syndromes，pid)如：(1)先天性丙種免疫球蛋白缺乏症(congenital agammaglobulinemia)及丙種免疫球蛋白過低症(hypogammaglobulinemia)(2)常見變異性免疫不全症(common variable immunodeficiency)(3)嚴重複合型免疫不全症(severe combined immunodeficiency)(4)wiskott- aldrich氏症候群2.慢性淋巴性白血病引致丙種免疫球蛋白過低與復發性細菌感染，且預防性抗生素治療無效的病人。3.多發性骨髓瘤穩定期(plateau phase)引致丙種免疫球蛋白過低與復發性細菌感染，且施打肺炎鏈球菌疫苗無效的病人。4.異體造血幹細胞移植後引致丙種免疫球蛋白過低。5.先天性愛滋病(aids)伴隨復發性細菌感染者。作為免疫調節：1.免疫性血小板缺乏紫斑症(immune thrombocytopenic purpura, itp)，且具高出血風險或用於手術前矯正血小板計數。2.格林-巴利症候群(guillain-barré syndrome)。3.川崎氏症(kawasaki disease) （與乙醯水楊酸acetylsalicylic acid一起使用；請參閱“劑量/用法”章節。）。4.慢性脫髓鞘多發性神經炎(chronic inflammatory demyelinating polyneuropathy, cidp)，對孩童的使用經驗有限。5.多灶性運動神經病變 (multifocal motor neuropathy, mmn)。6.重症肌無力惡化(myasthenia gravis exacerbations, mg)。7.藍伯-伊頓肌無力症(lambert-eaton myasthenic syndrome)。8.僵體徵候群(stiff person syndrome)。